New Horizons in the Treatment of Neurological Disorders with Tailorable Gold Nanoparticles

Farheen, Md Asad Khan*, Ghulam Md Ashraf, Anwar L. Bilgrami, M. Moshahid A. Rizvi

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

5 Citations (Scopus)

Abstract

Neurological disorders, such as epilepsy, dementia, Parkinson’s disease and Alzheimer’s disease, occur due to disorganization of the neurons in the nervous system. Disturbances in the nervous system cause problems with the memory, senses and moods. In order to treat such disorders, scientists have been working extensively, utilizing different approaches. Nanoneurotechnology has emerged as a promising tool to manage these complicated disorders, where nanoparticles with their tunable properties such as size, shape, increased solubility, biodegradability, surface area and sharp penetration through the biological barriers, target the central nervous system. This technology targets damaged neurons without affecting healthy neurons and the Blood-Brain Barrier (BBB). In this review, we discuss neurological disorders and challenges in their diagno-sis and treatment by emphasizing on the role of tailorable gold nanoparticles in therapeutic drug approaches.

Original languageEnglish
Pages (from-to)931-938
Number of pages8
JournalCurrent Drug Metabolism
Volume22
Issue number12
DOIs
Publication statusPublished - Oct 2021
Externally publishedYes

Keywords

  • Blood brain barrier
  • Gold nanoparticles
  • Nanotechnology
  • Neurodegeneration
  • Neurological disorders
  • Therapeutic drug approaches

Fingerprint

Dive into the research topics of 'New Horizons in the Treatment of Neurological Disorders with Tailorable Gold Nanoparticles'. Together they form a unique fingerprint.

Cite this